Investors eye Achillion for next big pharma deal
June 10, 2014 at 14:20 PM EDT
Achillion's been a takeover target for years. But Merck's acquisition of Idenix may mean Achillion's time has come.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|